News and Announcements
Alcidion Group (ASX: ALC) Acquires MKM Health & Patientrack
- Published April 25, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Alcidion Group Limited is a software business specialising in health informatics.
- Alcidion acquired MKM Health and Patientrack, two of the largest information technology businesses in the healthcare sector.
- The complete integration is aimed to be achieved by June 2018.
Alcidion Group Limited is a health informatics software company that has made an acquisition of MKM Health and Patientrack. MKM Health is an information technology business that offers products and services digitally to healthcare suppliers in Australia and New Zealand. MKM Health collaborated with Patientrack to be Patientrack’s information technology service provider and sole distributor. Patientrack is a United Kingdom-orientated healthcare software programme
that is aimed at refining patient security.
The acquisition will allow for a new network of technology to be available within the healthcare sector and will provide Alcidion with a larger client base and greater impression globally. Further, the acquisition will allow the company to expand its technology, information technology sales, its products, and its services. Therefore, this will allow Alcidion to increase its profit.
Ms Kate Quirke will be assigned the role of Chief Executive of the newly expanded Alcidion Federation and will be the Executive Director. The current CEO of Alcidion, Ray Blight, will become the Executive Chairman of the enlarged group. The expansion of Alcidion is part of its strategic basis for international recognition. The aim is to improve the proficiency of the
integrated healthcare sector from a business as well as clinical point of view. Completion of the merger between these healthcare information technology companies is expected by the end of June 2018.
About Alcidion Group Ltd (ASX: ALC)
Alcidion Corporation is an ASX-listed leading health informatics company founded by the former CEO of the SA Health Department and Professor Malcolm Pradhan.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
